Health Technology Assessment (HTA)

Size: px
Start display at page:

Download "Health Technology Assessment (HTA)"

Transcription

1 Health Technology Assessment (HTA) Determination of utilities for the QLQ-C30 Georg Kemmler, Eva Gamper, Bernhard Holzner Department for Psychiatry and Psychotherapy Innsbruck Medical University Austria

2 Introduction Increasing importance of health economics and HTA in cancer research ( cost-utility analyses) Special utility based QOL instruments are required for performing such analyses (like EQ-5D, SF-6D) Development of utility-based versions of the QLQ-C30 has been intiated, but so far restricted to English language versions (AUS, UK) ( next page) Versions for various European countries with national utility weights are required to make the QLQ-C30 a competitive utility instrument

3 Utilities for the EORTC QLQ-C30 The larger framework Study 1 (D Rowen, J Brazier et al.*): Utilities for the QLQ-C30 in multiple myeloma patients based on 8 of the 30 EORTC QLQ-C30 items (EORTC-8D, finished) Study 2 (M King et al.**): Utilities for the QLQ-C30 in a general population sample Stage 1: Determination of the number of domains (finished, 10 domains/items ) Stage 2: Determination of utilites by Discrete Choice Experiments (feasibility testing just started) Study 2a (EORTC QLG, in cooperation with M. King et al.): Country-specific utilities for the QLQ-C30 (planning phase) * Rowen D, Brazier JE, Young TA, Gaugrist S, Craig BM, King MT, Velikova G. Value Health 2011 ** Consortium on Multi-Attribute Utility in Cancer MAUCa (M King,, N Aaronson, G Velikova et al.)

4 Determination of Utilities for the QLQ-C30 Graphical illustration EORTC QLQ- C30 PF EF SF RF CF GQOL Pain Fatigue Nausea Dyspnea Appetite loss Sleep disturbances Diarrhea Constipation Financial Impact Stage 1: Selection of key dimensions for generating health states (IRT - MAUCa) EORTC xd PF RF SF EF Pain Fatigue Nausea Constipation/Diarrh Appetite loss Sleep disturb. Stage 2: Determination of utilities by DCE EORTC utility score x1 * PF + x2 * RF + x3 * SF + x4 * EF + x5 * Pain + x6 * Fatigue + x7 * Nausea + x8*constipation/d + x9 * Appetite l. + x10* Sleep d. Depending on country (i.p. health care system), population (cancer vs healthy)

5 Steps Planned EORTC utility project* 1. Selection of EORTC QLQ-C30 dimensions/key items 2. Decision for utility elicitation method: TTO or DCE 3. Pilot study: Testing the feasibility of Discrete Choice Experiments (DCE) for utility elicitation 4. Main study: Elicitation of utilities for the EORTC QLQ-C30 (for several European countries) 5. Statistical analyses: estimation of EORTC utility weights, comparison between countries *In close cooperation with Madeleine King and the MAUCa team

6 Testing the feasibility of Discrete Choice Experiments (DCE) for utility elicitation: First results of the Austrian pilot study Small sample of healthy controls (N=47), patients planned Each participant had to complete 12 individual DCEs (comparisons Life A vs. Life B ) Two different designs tested: black and white vs color ( ) Test acceptability and feasibility Test for an effect of the design/layout

7 What does a Discrete Choice Experiment (DCE) look like? Example (simplified): Which of the two lives would you prefer? You will live in this situation for... years and then die Situation A Situation B 5 years 2 years Your physical condition or medical treatment interferes with your social or family life Very much A little You feel depressed Not at all A little Pain interferes with your daily activities Not at all Quite a bit You feel nauseated Very much Not at all Which situation would you prefer? In our case: Not 4 dimensions but 10! More complex task!

8 Version 1: black and white No colors for different categories

9 Version 2: color green (not at all) yellow (a little) - orange (quite a bit) - red (very much)

10 Results 1: Sample characteristics Variable Category Population Sample (N=47) Cancer Patients ongoing Age (Mean ± SD) 36 ± 15 (18 95) Gender Male 51% Female 49% Education Lower than A-levels 15% A-levels (Matura) 22.5% University 62.5% Health status No chron. disease or cancer 90% Cancer 0% chron. diseases 10%

11 Results 2: Acceptability & Feasibility Acceptability All persons approached were willing to participate No complaints about annoying or intrusive questions However: possible selection bias (fairly high level of education!) Feasibility Every respondent was able to understand the task Clear explanations were essential (set of dimensions, severity levels) Problems were mentioned by a considerable proportion of persons (e.g. difficulties to imagine certain health states/ combinations)

12 Results 3: First statistical analyses In 7 of the 12 individual DCEs: clear preference for one to the two situations (>80% for one option, <20% for the other) In 5 of the 12 DCEs: opinions were more split Most influential dimensions: Nausea and Fatigue Color vs. black & white: Majority preferred color (73%), so far no significant differences between color and b & w Limitations Utilities for individual health states can not yet be determined too few cases, too few distinct DCEs

13 Summary: Aims of the planned EORTC QLG project General aim: Determination of country-specific utilities for the EORTC QLQ-C30 - many countries - population sample and possibly cancer patients Phase I: Country-specific utilities for a few European countries (general population sample)

14 Many thanks for your attention!

Health Technology Assessment (HTA)

Health Technology Assessment (HTA) Health Technology Assessment (HTA) Utilities for the QLQ-C30 an Update Plenary Session 11 th Sept., 2015, Krakow Georg Kemmler, Eva Gamper, Virginie Nerich, Bernhard Holzner Department of Psychiatry and

More information

Introducing the QLU-C10D A preference-based utility measure derived from the QLQ-C30

Introducing the QLU-C10D A preference-based utility measure derived from the QLQ-C30 Introducing the QLU-C10D A preference-based utility measure derived from the QLQ-C30 Presented by Professor Madeleine King Cancer Australia Chair in Cancer Quality of Life Faculties of Science and Medicine

More information

The QLQ-C30 cut-off project - Symptom screening with the EORTC quality of life scales

The QLQ-C30 cut-off project - Symptom screening with the EORTC quality of life scales The QLQ-C30 cut-off project - Symptom screening with the EORTC quality of life scales Johannes Giesinger Division of Psychosocial Research and Epidemiology The Netherlands Cancer Institute Amsterdam The

More information

Session 6: Choosing and using HRQoL measures vs Multi-Attribute Utility Instruments QLU-C10D and EQ-5D as examples

Session 6: Choosing and using HRQoL measures vs Multi-Attribute Utility Instruments QLU-C10D and EQ-5D as examples Session 6: Choosing and using HRQoL measures vs Multi-Attribute Utility Instruments QLU-C10D and EQ-5D as examples - Madeleine King & Richard De Abreu Lourenco- Overview Learning Objectives To discuss

More information

Background. 2 5/30/2017 Company Confidential 2015 Eli Lilly and Company

Background. 2 5/30/2017 Company Confidential 2015 Eli Lilly and Company May 2017 Estimating the effects of patient-reported outcome (PRO) diarrhea and pain measures on PRO fatigue: data analysis from a phase 2 study of abemaciclib monotherapy, a CDK4 and CDK6 inhibitor, in

More information

Mapping the EORTC QLQ C-30 onto the EQ-5D Instrument: The Potential to Estimate QALYs without Generic Preference Data

Mapping the EORTC QLQ C-30 onto the EQ-5D Instrument: The Potential to Estimate QALYs without Generic Preference Data Volume 12 Number 1 2009 VALUE IN HEALTH Mapping the EORTC QLQ C-30 onto the EQ-5D Instrument: The Potential to Estimate QALYs without Generic Preference Data Lynda McKenzie, MSc, Marjon van der Pol, PhD

More information

The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Validation study of the Thai version

The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Validation study of the Thai version Quality of Life Research (2006) 15: 167 172 Ó Springer 2006 DOI 10.1007/s11136-005-0449-7 Brief communication The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire

More information

This is a repository copy of Deriving a preference-based measure for cancer using the EORTC QLQ-C30.

This is a repository copy of Deriving a preference-based measure for cancer using the EORTC QLQ-C30. This is a repository copy of Deriving a preference-based measure for cancer using the EORTC QLQ-C30. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/10872/ Monograph: Rowen,

More information

PATIENTS REPORTED OUTCOMES IN ONCOLOGY PATIENT- CENTERED DRUG DEVELOPMENT: OPPORTUNITIES & CHALLENGES

PATIENTS REPORTED OUTCOMES IN ONCOLOGY PATIENT- CENTERED DRUG DEVELOPMENT: OPPORTUNITIES & CHALLENGES PATIENTS REPORTED OUTCOMES IN ONCOLOGY PATIENT- CENTERED DRUG DEVELOPMENT: OPPORTUNITIES & CHALLENGES 10th Alpine Conference Innsbruck, Austria, 27 February 2018 1 Disclaimer The views and opinions expressed

More information

EORTC QLQ-C30 descriptive analysis with the qlqc30 command

EORTC QLQ-C30 descriptive analysis with the qlqc30 command The Stata Journal (2015) 15, Number 4, pp. 1060 1074 EORTC QLQ-C30 descriptive analysis with the qlqc30 command Caroline Bascoul-Mollevi Biostatistics Unit CTD INCa, Institut régional du Cancer de Montpellier

More information

Quality of life in (haemato)oncology

Quality of life in (haemato)oncology Copyright Statement As a registered E-materials Service user of the EBMT Annual Meeting in Marseille March 26-29th 2017, you have been granted permission to access a copy of the presentation in the following

More information

Do patients consider computer-adaptive measures more appropriate than static questionnaires?

Do patients consider computer-adaptive measures more appropriate than static questionnaires? Gamper et al. Journal of Patient-Reported Outcomes (2019) 3:7 https://doi.org/10.1186/s41687-019-0096-3 Journal of Patient- Reported Outcomes RESEARCH Do patients consider computer-adaptive measures more

More information

Quality of Life and Survivorship:

Quality of Life and Survivorship: Quality of Life and Survivorship: Implications for Future Ovarian Cancer Research and Care Lari Wenzel, PhD Professor of Medicine & Public Health Associate Director, Population Science and Cancer Control

More information

Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients

Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients Kim et al. Health and Quality of Life Outcomes 2012, 10:151 RESEARCH Open Access Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients Seon Ha Kim 1, Min-Woo Jo 1*, Hwa-Jung Kim 2 and

More information

Københavns Universitet

Københavns Universitet university of copenhagen Københavns Universitet The EORTC emotional functioning computerized adaptive test Gamper, Eva-Maria; Grønvold, Mogens; Petersen, Morten Aa; Young, Teresa; Costantini, Anna; Aaronson,

More information

Health Related Quality of Life: Cancer cachexia. Professor Graeme D. Smith Editor Journal of Clinical Nursing CMU,Taiwan August 2017

Health Related Quality of Life: Cancer cachexia. Professor Graeme D. Smith Editor Journal of Clinical Nursing CMU,Taiwan August 2017 Health Related Quality of Life: Cancer cachexia Professor Graeme D. Smith Editor Journal of Clinical Nursing CMU,Taiwan August 2017 Overview to lecture Introduction/Scotland Patient related outcome measures

More information

Patient-reported outcome

Patient-reported outcome Patient-reported outcome How does it compare to EORTC QOL assessment in EMBRACE? Pilot testing in Vienna Kathrin Kirchheiner, Elke Dörr EORTC Answer categories not precise It remains unclear if frequency,

More information

Change in health-related quality of life over 1 month in cancer patients with high initial levels of symptoms and problems

Change in health-related quality of life over 1 month in cancer patients with high initial levels of symptoms and problems Syddansk Universitet Change in health-related quality of life over 1 month in cancer patients with high initial levels of symptoms and problems Lund Rasmussen, Charlotte; Johnsen, Anna Thit; Petersen,

More information

Implementing Patient Report Outcome Data in Clinical Trials Analysis

Implementing Patient Report Outcome Data in Clinical Trials Analysis PharmaSUG 2017 - Paper PO04 Implementing Patient Report Outcome Data in Clinical Trials Analysis ABSTRACT Qi Wang, Amgen, Thousand Oaks, CA Over the recent decades, Health-Related Quality of Life (HRQoL)

More information

Japan Journal of Medicine

Japan Journal of Medicine 29 Japan Journal of Medicine 28; (6): 29-296. doi:.3488/jjm.3 Research article An International comparative Study on EuroQol-5-Dimension Questionnaire (EQ-5D) tariff scores between the and Japan Tsuguo

More information

Table of Contents. Preface to the third edition xiii. Preface to the second edition xv. Preface to the fi rst edition xvii. List of abbreviations xix

Table of Contents. Preface to the third edition xiii. Preface to the second edition xv. Preface to the fi rst edition xvii. List of abbreviations xix Table of Contents Preface to the third edition xiii Preface to the second edition xv Preface to the fi rst edition xvii List of abbreviations xix PART 1 Developing and Validating Instruments for Assessing

More information

Anota et al. Health and Quality of Life Outcomes 2014, 12:32

Anota et al. Health and Quality of Life Outcomes 2014, 12:32 Anota et al. Health and Quality of Life Outcomes 2014, 12:32 RESEARCH Open Access Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality

More information

Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients

Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients Original article Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients E.S. CANKURTARAN, md, Ankara Oncology Training and Research Hospital, Psychiatry Clinic, Ankara,

More information

Quality of Life. The assessment, analysis and reporting of patient-reported outcomes. Third Edition

Quality of Life. The assessment, analysis and reporting of patient-reported outcomes. Third Edition Quality of Life The assessment, analysis and reporting of patient-reported outcomes Third Edition PETER M. FAYERS Institute of Applied Health Sciences, University ofaberdeen School of Medicine and Dentistry,

More information

Author Block M. Fisch, J. W. Lee, J. Manola, L. Wagner, V. Chang, P. Gilman, K. Lear, L. Baez, C. Cleeland University of Texas M.D. Anderson Cancer Ce

Author Block M. Fisch, J. W. Lee, J. Manola, L. Wagner, V. Chang, P. Gilman, K. Lear, L. Baez, C. Cleeland University of Texas M.D. Anderson Cancer Ce Survey of disease and treatment-related t t related symptoms in outpatients with invasive i cancer of the breast, prostate, lung, or colon/rectum (E2Z02, the SOAPP study, Abst # 9619) Michael J. Fisch,

More information

The Quality of Life of Chinese Middle-Aged Male Patients with Gastric Carcinoma After Total Gastrectomy and Nursing Intervention

The Quality of Life of Chinese Middle-Aged Male Patients with Gastric Carcinoma After Total Gastrectomy and Nursing Intervention Clin Oncol Cancer Res (2010) 7: 151-156 DOI 10.1007/s11805-010-0511-2 151 The Quality of Life of Chinese Middle-Aged Male Patients with Gastric Carcinoma After Total Gastrectomy and Nursing Intervention

More information

QUALITY OF LIFE IN CANCER CLINICAL TRIALS A Practical Guide For. Research Staff

QUALITY OF LIFE IN CANCER CLINICAL TRIALS A Practical Guide For. Research Staff QUALITY OF LIFE IN CANCER CLINICAL TRIALS A Practical Guide For Research Staff Contents What is Quality of Life?.. 1 QOL in Cancer Trials. 2 How is QOL Measured?....3 EORTC Questionnaires.....4 FACIT Questionnaires..

More information

ALK Inhibition: From Biology to Approved Therapy for Advanced Non-Small Cell Lung Cancer

ALK Inhibition: From Biology to Approved Therapy for Advanced Non-Small Cell Lung Cancer ALK Inhibition: From Biology to Approved Therapy for Advanced Non-Small Cell Lung Cancer Dr. Ben Solomon Medical Oncologist, Thoracic Oncology Peter MacCallum Cancer Centre Melbourne, Australia Dr. D.

More information

Fanxing Hong 1*, Jaclyn L F Bosco 2, Nigel Bush 3 and Donna L Berry 2

Fanxing Hong 1*, Jaclyn L F Bosco 2, Nigel Bush 3 and Donna L Berry 2 Hong et al. BMC Cancer 2013, 13:165 RESEARCH ARTICLE Open Access Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment

More information

How to Measure and Value Health Benefits to Facilitate Priority Setting for Pediatric Population? Development and Application Issues.

How to Measure and Value Health Benefits to Facilitate Priority Setting for Pediatric Population? Development and Application Issues. IP12 How to Measure and Value Health Benefits to Facilitate Priority Setting for Pediatric Population? Development and Application Issues 17:00 18:00 September 10 1 Speakers Gang Chen Ruoyan Gai Nan Luo

More information

Patient Reported Outcomes

Patient Reported Outcomes Patient Reported Outcomes INTRODUCTION TO CLINICAL RESEARCH A TWO-WEEK INTENSIVE COURSE, 2010 Milo Puhan, MD, PhD, Associate Professor Key messages Patient-reported outcomes (PRO) is a broad group of outcomes

More information

Original Article on Palliative Radiotherapy

Original Article on Palliative Radiotherapy Original Article on Palliative Radiotherapy Quality of life in responders after palliative radiation therapy for painful bone metastases using EORTC QLQ-C30 and EORTC QLQ- BM22: results of a Brazilian

More information

10th anniversary of 1st validated CaPspecific

10th anniversary of 1st validated CaPspecific Quality of Life after Treatment of Localised Prostate Cancer Dr Jeremy Grummet Clinical Uro-Oncology Fellow May 28, 2008 1 Why? This is important May be viewed as soft science Until we know which treatment

More information

Chika Nwachukwu, Ph.D. MS IV Radiation Oncology Rotation

Chika Nwachukwu, Ph.D. MS IV Radiation Oncology Rotation Chika Nwachukwu, Ph.D. MS IV Radiation Oncology Rotation Background Histology/Tumor Characteristics Presenting Symptoms/diagnosis Treatment/outcome Patient cohort Research on HRQOL Slow growing indolent

More information

Quality Of Life Of The Patients With Ovarian Cancer

Quality Of Life Of The Patients With Ovarian Cancer ISPUB.COM The Internet Journal of Oncology Volume 7 Number 2 M Zamurovic, Z Perisic Citation M Zamurovic, Z Perisic.. The Internet Journal of Oncology. 2009 Volume 7 Number 2. Abstract PURPOSE: The goal

More information

Prof Marion Eckert Rosemary Bryant AO Research Centre

Prof Marion Eckert Rosemary Bryant AO Research Centre Willingness of cancer survivors to complete patient reported outcomes (PRO) surveys: a pilot study at Flinders Centre for Innovation in Cancer (FCIC), South Australia Prof Marion Eckert Rosemary Bryant

More information

THE UNIVERSITY OF SYDNEY CANCER RESEARCH NETWORK QUALITY OF LIFE SHOWCASE

THE UNIVERSITY OF SYDNEY CANCER RESEARCH NETWORK QUALITY OF LIFE SHOWCASE THE UNIVERSITY OF SYDNEY CANCER RESEARCH NETWORK QUALITY OF LIFE SHOWCASE Friday, 6 October 2017 3.00 5.00pm (with light refreshments to follow) Seminar Room 022, New Law Building Eastern Ave, (Camperdown

More information

Women s Health Development Unit, School of Medical Science, Health Campus, Universiti Sains Malaysia b

Women s Health Development Unit, School of Medical Science, Health Campus, Universiti Sains Malaysia b The Malay Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ C30): Reliability and Validity Study Yusoff N a, Low WY b and Yip CH c ORIGINAL

More information

Author's response to reviews

Author's response to reviews Author's response to reviews Title: Evaluation of Safety and Efficacy of Gefitinib ('Iressa', ZD1839) as Monotherapy in a series of Chinese Patients with Advanced Non-small-cell Lung Cancer: Experience

More information

LARYNGEAL CANCER IN EGYPT: QUALITY OF LIFE MEASUREMENT WITH DIFFERENT TREATMENT MODALITIES

LARYNGEAL CANCER IN EGYPT: QUALITY OF LIFE MEASUREMENT WITH DIFFERENT TREATMENT MODALITIES ORIGINAL ARTICLE LARYNGEAL CANCER IN EGYPT: QUALITY OF LIFE MEASUREMENT WITH DIFFERENT TREATMENT MODALITIES Ossama A. Hamid, MD, 1 Lobna M. El Fiky, MD, 1 Medani M. Medani, MD, 1 Ayman AbdelHady, MBBCh,

More information

Multidimensional fatigue and its correlates in hospitalized advanced cancer patients

Multidimensional fatigue and its correlates in hospitalized advanced cancer patients Chapter 5 Multidimensional fatigue and its correlates in hospitalized advanced cancer patients Michael Echtelda,b Saskia Teunissenc Jan Passchierb Susanne Claessena, Ronald de Wita Karin van der Rijta

More information

A SAS Application for Analyzing Quality of Life data: NCIC-CTG Standard Method

A SAS Application for Analyzing Quality of Life data: NCIC-CTG Standard Method Paper SP01 A SAS Application for Analyzing Quality of Life data: NCIC-CTG Standard Method Don (Dongguang) Li, NCIC-CTG, Queen s University, Kingston, ON, Canada ABSTRACT The Health-Related Quality of Life

More information

VALUE IN HEALTH 19 (2016) Available online at journal homepage:

VALUE IN HEALTH 19 (2016) Available online at   journal homepage: VALUE IN HEALTH 19 (2016) 834 843 Available online at www.sciencedirect.com journal homepage: www.elsevier.com/locate/jval PREFERENCE-BASED ASSESSMENTS Which Questionnaire Should Be Used to Measure Quality-of-Life

More information

The Relationship Between Cancer-Related Fatigue and Patient Satisfaction with Quality of Life in Cancer

The Relationship Between Cancer-Related Fatigue and Patient Satisfaction with Quality of Life in Cancer 40 Journal of Pain and Symptom Management Vol. 34 No. 1 July 2007 Original Article The Relationship Between Cancer-Related Fatigue and Patient Satisfaction with Quality of Life in Cancer Digant Gupta,

More information

Symptom Benefit Committee. Chicago May 2018 F. Hilpert/JE Kurtz

Symptom Benefit Committee. Chicago May 2018 F. Hilpert/JE Kurtz Symptom Benefit Committee Chicago May 2018 F. Hilpert/JE Kurtz Symptom Benefit Committee Published studies SOLO 2-QoL accepted in Lancet Oncology NOVA-QoL submitted MOST questionnaire Update: ongoing studies

More information

Quality of Life assessment: A perspective from The EORTC

Quality of Life assessment: A perspective from The EORTC Quality of Life assessment: A perspective from The EORTC Presentation to the European Commission Iniciative in Breast Cancer meeting Andrew Bottomley, PhD Assistant Director, Head of the QOL Department

More information

Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D

Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D HEALTH-RELATED QUALITY OF LIFE Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D Matthijs M. Versteegh, MA, Annemieke Leunis, MSc, Jolanda J. Luime, PhD, Mike Boggild, MD, MRCP, Carin A. Uyl-de Groot, PhD, Elly

More information

ANZGOG Update. Symptom Working Group. Presentation prepared by Michael Friedlander

ANZGOG Update. Symptom Working Group. Presentation prepared by Michael Friedlander ANZGOG Update Symptom Working Group Presentation prepared by Michael Friedlander GCIG Symptom Benefit Study Baseline quality of life as a predictor of early cessation of chemotherapy and survival in platinum

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Basch E, Dueck AC, Rogak LJ, et al. Feasibility assessment of patient reporting of symptomatic adverse events in multicenter cancer clinical trials. JAMA Oncol. Published online

More information

Major Challenges in Danish Cancer Care

Major Challenges in Danish Cancer Care Major Challenges in Danish Cancer Care Every 3.th gets cancer and every 4.th die of cancer 230.000 live with cancer Incidence increases by 30% the next 12 years Increasing survivorship and co-morbidity

More information

Patient Reported Outcomes (PROs) Tools for Measurement of Health Related Quality of Life

Patient Reported Outcomes (PROs) Tools for Measurement of Health Related Quality of Life Patient Reported Outcomes (PROs) Tools for Measurement of Health Related Quality of Life David Victorson, Ph.D. Assistant Professor Department of Medical Social Sciences Northwestern University Feinberg

More information

Reliability and Validity of the Taiwan Chinese Version of the EORTC QLQ-PR25 in Assessing Quality of Life of Prostate Cancer Patients

Reliability and Validity of the Taiwan Chinese Version of the EORTC QLQ-PR25 in Assessing Quality of Life of Prostate Cancer Patients Urol Sci 2010;21(3):118 125 ORIGINAL ARTICLE Reliability and Validity of the Taiwan Chinese Version of the EORTC QLQ-PR25 in Assessing Quality of Life of Prostate Cancer Patients Wei-Chu Chie 1, Chih-Chieh

More information

Table 1: Controlled clinical trials of aromatherapy for cancer

Table 1: Controlled clinical trials of aromatherapy for cancer Table 1: Controlled clinical trials of aromatherapy for cancer Source: Helen Seers, Katja Boehm, CAM-Cancer Consortium. Aromatherapy [online document]. http://www.cam-cancer.org/cam- Summaries/Herbal-products/Aromatherapy/Aromatherapy-Table-1,

More information

Cross-cultural Psychometric Evaluation of the Dutch McGill- QoL Questionnaire for Breast Cancer Patients

Cross-cultural Psychometric Evaluation of the Dutch McGill- QoL Questionnaire for Breast Cancer Patients Facts Views Vis Obgyn, 2016, 8 (4): 205-209 Original paper Cross-cultural Psychometric Evaluation of the Dutch McGill- QoL Questionnaire for Breast Cancer Patients T. De Vrieze * 1,2, D. Coeck* 1, H. Verbelen

More information

Sanjeewa Kularatna 1,2*, Jennifer A. Whitty 1,2,3, Newell W. Johnson 2, Ruwan Jayasinghe 4 and Paul A. Scuffham 1,2

Sanjeewa Kularatna 1,2*, Jennifer A. Whitty 1,2,3, Newell W. Johnson 2, Ruwan Jayasinghe 4 and Paul A. Scuffham 1,2 Kularatna et al. Health and Quality of Life Outcomes (2016) 14:101 DOI 10.1186/s12955-016-0502-y RESEARCH A comparison of health state utility values associated with oral potentially malignant disorders

More information

Symptom clusters using the EORTC QLQ-C15-PAL in palliative radiotherapy

Symptom clusters using the EORTC QLQ-C15-PAL in palliative radiotherapy Original Article Symptom clusters using the EORTC QLQ-C15-PAL in palliative radiotherapy Vithusha Ganesh, Liying Zhang, Bo Angela Wan, Leah Drost, May Tsao, Elizabeth Barnes, Carlo DeAngelis, Hans Chung,

More information

Quality of life of patients after low anterior, intersphincteric, and abdominoperineal resection for rectal cancer a matched-pair analysis

Quality of life of patients after low anterior, intersphincteric, and abdominoperineal resection for rectal cancer a matched-pair analysis Int J Colorectal Dis (2013) 28:679 688 DOI 10.1007/s00384-013-1683-z ORIGINAL ARTICLE Quality of life of patients after low anterior, intersphincteric, and abdominoperineal resection for rectal cancer

More information

COVERAGE WITH EVIDENCE DEVELOPMENT

COVERAGE WITH EVIDENCE DEVELOPMENT COVERAGE WITH EVIDENCE DEVELOPMENT OVERVIEW AND USE TO PROMOTE BIOMARKER DEVELOPMENT IOM National Cancer Policy Forum Sean Tunis, MD, MSc November 10, 2014 CED DEFINITION AND PURPOSE Reimbursement that

More information

PROMIS-29 V2.0 Physical and Mental Health Summary Scores. Ron D. Hays. Karen L. Spritzer, Ben Schalet, Dave Cella. September 27, 2017, 3:30-4:00pm

PROMIS-29 V2.0 Physical and Mental Health Summary Scores. Ron D. Hays. Karen L. Spritzer, Ben Schalet, Dave Cella. September 27, 2017, 3:30-4:00pm PROMIS-29 V2.0 Physical and Mental Health Summary Scores Ron D. Hays Karen L. Spritzer, Ben Schalet, Dave Cella September 27, 2017, 3:30-4:00pm HealthMeasures User Conference Track B: Enhancing Quality

More information

Validation Study of the Korean Version of the Brief Fatigue Inventory

Validation Study of the Korean Version of the Brief Fatigue Inventory Vol. 29 No. 2 February 2005 Journal of Pain and Symptom Management 165 Original Article Validation Study of the Korean Version of the Brief Fatigue Inventory Young Ho Yun, MD, PhD, Xin Shelley Wang, MD,

More information

INSTRUCTION MANUAL Instructions for Patient Health Questionnaire (PHQ) and GAD-7 Measures

INSTRUCTION MANUAL Instructions for Patient Health Questionnaire (PHQ) and GAD-7 Measures PHQ and GAD-7 Instructions P. 1/9 INSTRUCTION MANUAL Instructions for Patient Health Questionnaire (PHQ) and GAD-7 Measures TOPIC PAGES Background 1 Coding and Scoring 2, 4, 5 Versions 3 Use as Severity

More information

Improving quality of life for people with dementia: the ADI-Stroud symposia

Improving quality of life for people with dementia: the ADI-Stroud symposia Improving quality of life for people with dementia: the ADI-Stroud symposia Sube Banerjee - I stitute of Ps hiat, Ki g s College Lo do Barry Gurland - Stroud Center, Columbia University Nori Graham - Alzhei

More information

Sleep Insomnia Severity Index (SISI) Pittsburgh Sleep Quality Inventory. POMS Vigor subscale

Sleep Insomnia Severity Index (SISI) Pittsburgh Sleep Quality Inventory. POMS Vigor subscale Physical GLOBAL HEALTH PROMIS completed already Sleep PROMIS-Sleep Sleep Insomnia Severity Index () Pittsburgh Sleep Quality Inventory 8 items 7 items 18 items Vigor Vigor subscale 6 items 1 Sleep- PROMIS

More information

A non-linear beta-binomial regression model for mapping EORTC QLQ- C30 to the EQ-5D-3L in lung cancer patients: a comparison with existing approaches

A non-linear beta-binomial regression model for mapping EORTC QLQ- C30 to the EQ-5D-3L in lung cancer patients: a comparison with existing approaches Khan and Morris Health and Quality of Life Outcomes 2014, 12:163 RESEARCH Open Access A non-linear beta-binomial regression model for mapping EORTC QLQ- C30 to the EQ-5D-3L in lung cancer patients: a comparison

More information

Original Article. Abstract. Introduction. Das Priscilla 1, Awang Hamidin 2, Md Zain Azhar 2, Kon Noorjan 2, Md Said Salmiah 1, Khalid Bahariah 3

Original Article. Abstract. Introduction. Das Priscilla 1, Awang Hamidin 2, Md Zain Azhar 2, Kon Noorjan 2, Md Said Salmiah 1, Khalid Bahariah 3 Original Article The Socio-Demographic and Clinical Factors Associated with Quality of Life among Patients with Haematological Cancer in a Large Government Hospital in Malaysia Das Priscilla 1, Awang Hamidin

More information

Ousmen et al. Health and Quality of Life Outcomes (2016) 14:167 DOI /s

Ousmen et al. Health and Quality of Life Outcomes (2016) 14:167 DOI /s Ousmen et al. Health and Quality of Life Outcomes (2016) 14:167 DOI 10.1186/s12955-016-0569-5 RESEARCH Impact of the occurrence of a response shift on the determination of the minimal important difference

More information

Comparing Health Outcomes in Comparative Effectiveness Research: Do preferences matter? Benjamin M. Craig, Ph.D

Comparing Health Outcomes in Comparative Effectiveness Research: Do preferences matter? Benjamin M. Craig, Ph.D Comparing Health Outcomes in Comparative Effectiveness Research: Do preferences matter? Benjamin M. Craig, Ph.D H. Lee Moffitt Cancer Center & Research Institute Comparative Effectiveness Research Comparative

More information

3/5/2014. New Research Initiatives to Improve QoL of Persons with SCI Across the Globe. What Are the SCI International Datasets?

3/5/2014. New Research Initiatives to Improve QoL of Persons with SCI Across the Globe. What Are the SCI International Datasets? New Research Initiatives to Improve QoL of Persons with SCI Across the Globe International SCI Conference: Toward Better Quality of Life Sultan Bin Abdulaziz Humanitarian City Riyadh, KSA Tamara Bushnik,

More information

15D: Strengths, weaknesses and future development

15D: Strengths, weaknesses and future development 15D: Strengths, weaknesses and future development Harri Sintonen University of Helsinki and FinOHTA Definition of health-related quality of life HRQoL instruments usually try, as does the 15D, to cover

More information

Stated Preference Methods Research in Health Care Decision Making A Critical Review of Its Use in the European Regulatory Environment.

Stated Preference Methods Research in Health Care Decision Making A Critical Review of Its Use in the European Regulatory Environment. Stated Preference Methods Research in Health Care Decision Making A Critical Review of Its Use in the European Regulatory Environment. Kevin Marsh, Evidera Axel Mühlbacher, Hochschule Neubrandenburg Janine

More information

CHAPTER - III METHODOLOGY

CHAPTER - III METHODOLOGY 74 CHAPTER - III METHODOLOGY This study was designed to determine the effectiveness of nurse-led cardiac rehabilitation on adherence and quality of life among patients with heart failure. 3.1. RESEARCH

More information

ISSN: X (Print) X (Online) Journal homepage:

ISSN: X (Print) X (Online) Journal homepage: Acta Oncologica SSN: 0284-186X (Print) 1651-226X (Online) Journal homepage: http://www.tandfonline.com/loi/ionc20 Quality of Life During Chemotherapy for Small Cell Lung Cancer:. A longitudinal study of

More information

Electronic Capture of PROs in NCI Clinical Trials

Electronic Capture of PROs in NCI Clinical Trials Electronic Capture of PROs in NCI Clinical Trials Lori Minasian, MD, FACP Deputy Director, Division of Cancer Prevention, NCI July 27, 2017 Vision for PROs in NCI Clinical Trials Incorporate patient reported

More information

Quality of life across chemotherapy lines in patients with advanced colorectal cancer: a prospective single-center observational study

Quality of life across chemotherapy lines in patients with advanced colorectal cancer: a prospective single-center observational study Quality of life across chemotherapy lines in patients with advanced colorectal cancer: a prospective single-center observational study Beate Mayrbäurl, Johannes M. Giesinger, Sonja Burgstaller, Gudrun

More information

ADDIS ABABA UNIVERSITY SCHOOL OF ALLIED HEALTH COLLEGE OF HEALTH SCIENCE DEPARTMENT OF NURSING AND MIDWIFERY

ADDIS ABABA UNIVERSITY SCHOOL OF ALLIED HEALTH COLLEGE OF HEALTH SCIENCE DEPARTMENT OF NURSING AND MIDWIFERY ADDIS ABABA UNIVERSITY SCHOOL OF ALLIED HEALTH COLLEGE OF HEALTH SCIENCE DEPARTMENT OF NURSING AND MIDWIFERY FACTORS ASSOCIATED WITH QUALITY OF LIFE IN ADULT CANCER PATIENTS UNDERTAKING CHEMOTHERAPY IN

More information

UvA-DARE (Digital Academic Repository)

UvA-DARE (Digital Academic Repository) UvA-DARE (Digital Academic Repository) Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust Giesinger, J.M.; Kieffer, J.M.; Fayers, P.M.;

More information

Patient Reported Outcomes in an Era of Immunotherapy Drug Development. David Cella, PhD Northwestern University Chicago, IL, USA

Patient Reported Outcomes in an Era of Immunotherapy Drug Development. David Cella, PhD Northwestern University Chicago, IL, USA Patient Reported Outcomes in an Era of Immunotherapy Drug Development David Cella, PhD Northwestern University Chicago, IL, USA Disclosures Research Grants: National Institutes of Health, Patient Centered

More information

The Origins and Promise of PROMIS Patient Reported Outcomes Measurement Information System

The Origins and Promise of PROMIS Patient Reported Outcomes Measurement Information System The Origins and Promise of PROMIS Patient Reported Outcomes Measurement Information System Gene A. Kallenberg, MD Professor and Chief, Division of Family Medicine Director, UCSD Center for Integrative

More information

European Wind Energy Association Oxford 12th December 2012

European Wind Energy Association Oxford 12th December 2012 European Wind Energy Association Oxford 12th December 2012 Noise Impact non-acoustic variables Ian Flindell ISVR, University of Southampton ian.flindell@btconnect.com General overview primary research

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Cohen DJ, Van Hout B, Serruys PW, et al. Quality of life after

More information

PROMIS Overview: Development of New Tools for Measuring Health-related Quality of Life and Related Outcomes in Patients with Chronic Diseases

PROMIS Overview: Development of New Tools for Measuring Health-related Quality of Life and Related Outcomes in Patients with Chronic Diseases PROMIS Overview: Development of New Tools for Measuring Health-related Quality of Life and Related Outcomes in Patients with Chronic Diseases William Riley, Ph.D. National Heart, Lung, and Blood Institute

More information

CHAPTER 3 RESEARCH METHODOLOGY

CHAPTER 3 RESEARCH METHODOLOGY CHAPTER 3 RESEARCH METHODOLOGY The present study was planned at evaluating the outcomes of pharmacological management of breast cancer in a tertiary care centre in Udupi district of Karnataka, India. An

More information

In Woong Han 1, O Choel Kwon 1, Min Gu Oh 1, Yoo Shin Choi 2, and Seung Eun Lee 2. Departments of Surgery, Dongguk University College of Medicine 2

In Woong Han 1, O Choel Kwon 1, Min Gu Oh 1, Yoo Shin Choi 2, and Seung Eun Lee 2. Departments of Surgery, Dongguk University College of Medicine 2 Effect of Rowachol on Prevention of Postcholecystectomy Syndrome after Laparoscopic Cholecystectomy - Prospective multicenter Randomized controlled trial- In Woong Han 1, O Choel Kwon 1, Min Gu Oh 1, Yoo

More information

DEVELOPMENT THE VALIDATION OF INDONESIAN VERSION OF SF-36 QUESTIONNAIRE IN CANCER DISEASE. Dyah Ariani Perwitasari

DEVELOPMENT THE VALIDATION OF INDONESIAN VERSION OF SF-36 QUESTIONNAIRE IN CANCER DISEASE. Dyah Ariani Perwitasari Short Communication Indonesian J. Pharm. Vol. 23 No. 4 : 248 253 ISSN-p : 0126-1037 DEVELOPMENT THE VALIDATION OF INDONESIAN VERSION OF SF-36 QUESTIONNAIRE IN CANCER DISEASE Dyah Ariani Perwitasari Faculty

More information

Quality of Life in Patients with Chronic Myeloid Leukemia

Quality of Life in Patients with Chronic Myeloid Leukemia Quality of Life in Patients with Chronic Myeloid Leukemia Fabio Efficace, PhD Chairman GIMEMA WP Quality of Life Head, Health Outcomes Research Unit Italian Group for Adult Hematologic Diseases (GIMEMA)

More information

Symptom Assessment Scale (SAS) + Palliative Care Problem Severity Score (PCPSS)

Symptom Assessment Scale (SAS) + Palliative Care Problem Severity Score (PCPSS) Symptom Assessment Scale (SAS) + Palliative Care Problem Severity Score (PCPSS) Funded under the National Palliative Care Program and is supported by the Australian Government Department of Health and

More information

Be A Lab Rat - With Open2.net THE STROOP-TEST: CONFLICTING MESSAGES IN THE BRAIN

Be A Lab Rat - With Open2.net THE STROOP-TEST: CONFLICTING MESSAGES IN THE BRAIN THE STROOP-TEST: CONFLICTING MESSAGES IN THE BRAIN In the sleep deprivation programme, a sleep-challenged Mike went head-to-head in a series of brain teasers with the cognitively-gifted IQ kid. One of

More information

Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme

Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme Eur J Nucl Med Mol Imaging (2015) 42:1179 1188 DOI 10.1007/s00259-015-3022-9 ORIGINAL ARTICLE Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring

More information

Health-Related Quality of Life in Brain Tumor Patients Treated with Surgery: Preliminary Result of a Single Institution

Health-Related Quality of Life in Brain Tumor Patients Treated with Surgery: Preliminary Result of a Single Institution ORIGINAL ARTICLE Brain Tumor Res Treat 2016;4(2):87-93 / pissn 2288-2405 / eissn 2288-2413 http://dx.doi.org/10.14791/btrt.2016.4.2.87 Health-Related Quality of Life in Brain Tumor Patients Treated with

More information

OVERALL CLINICAL BENEFIT

OVERALL CLINICAL BENEFIT noted that there are case reports of a rebound effect upon discontinuation of ruxolitinib (Tefferi 2012), although this was not observed in either the COMFORT I or COMFORT II studies. Therefore, perc considered

More information

DISABILITY, PSYCHOLOGICAL DISTRESS AND QUALITY OF LIFE IN BREAST CANCER SURVIVORS WITH ARM LYMPHEDEMA

DISABILITY, PSYCHOLOGICAL DISTRESS AND QUALITY OF LIFE IN BREAST CANCER SURVIVORS WITH ARM LYMPHEDEMA 185 Lymphology 39 (2006) 185-192 DISABILITY, PSYCHOLOGICAL DISTRESS AND QUALITY OF LIFE IN BREAST CANCER SURVIVORS WITH ARM LYMPHEDEMA A. Pyszel, K. Malyszczak, K. Pyszel, R. Andrzejak, A. Szuba Departments

More information

Quality of life in patients with a permanent stoma after rectal cancer surgery

Quality of life in patients with a permanent stoma after rectal cancer surgery Qual Life Res (2017) 26:55 64 DOI 10.1007/s11136-016-1367-6 Quality of life in patients with a permanent stoma after rectal cancer surgery Pia Näsvall 1,2 Ursula Dahlstrand 3 Thyra Löwenmark 3 Jörgen Rutegård

More information

J Clin Oncol 25: by American Society of Clinical Oncology INTRODUCTION

J Clin Oncol 25: by American Society of Clinical Oncology INTRODUCTION VOLUME 25 NUMBER 15 MAY 20 2007 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E O R T Controlled Study of Fatigue, Quality of Life, and Somatic and Mental Morbidity in Epithelial Ovarian Cancer Survivors:

More information

LIHS Mini Master Class

LIHS Mini Master Class Alexandru Nicusor Matei 2013 CC BY-NC-ND 2.0 Measurement and valuation of health using QALYS John O Dwyer Academic Unit of Health Economics John O Dwyer University of Leeds 2015. This work is made available

More information

Instruments Available for Use in Assessment Center

Instruments Available for Use in Assessment Center Instruments Available for Use in Assessment Center The Assessment Center Instrument Library includes instruments from PROMIS, Neuro-QoL, NIH Toolbox and Health LiTT. All instruments are available for use

More information

Running head: ARTICLE CRITIQUE 1

Running head: ARTICLE CRITIQUE 1 Running head: ARTICLE CRITIQUE 1 Article Critique Anonymous Student Anonymous University ARTICLE CRITIQUE 2 Introduction The effect of linguistic tendencies on behaviors is an interesting field for research;

More information

Qualitative Methods and Patient Reported Outcome Measures. Susan C Pitt, MD, MPHS Assistant Professor of Surgery University of Wisconsin

Qualitative Methods and Patient Reported Outcome Measures. Susan C Pitt, MD, MPHS Assistant Professor of Surgery University of Wisconsin Qualitative Methods and Patient Reported Outcome Measures Susan C Pitt, MD, MPHS Assistant Professor of Surgery University of Wisconsin Disclosures None Overview What is it? When is it useful? Why do it?

More information

Are touchscreen computer surveys acceptable to medical oncology patients?

Are touchscreen computer surveys acceptable to medical oncology patients? Southern Cross University epublications@scu School of Education 1997 Are touchscreen computer surveys acceptable to medical oncology patients? Sallie Newell Southern Cross University Rob William Sanson-Fisher

More information

Assessment of quality of life in patients with breast cancer receiving chemotherapy

Assessment of quality of life in patients with breast cancer receiving chemotherapy Research Article Assessment of quality of life in patients with breast cancer receiving * ABSTRACT Aim: The aim of the study is to assess the quality of life (QoL) in patients with breast cancer receiving.

More information

A Gynecologic Cancer Intergroup Study of the NCIC Clinical Trials Group (NCIC CTG), the European Organization for Research and

A Gynecologic Cancer Intergroup Study of the NCIC Clinical Trials Group (NCIC CTG), the European Organization for Research and Randomized study of sequential cisplatintopotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life A Gynecologic Cancer Intergroup Study of the NCIC Clinical Trials Group

More information